Skip to main content

Adzynma Side Effects

Generic name: apadamtase alfa, recombinant

Medically reviewed by Drugs.com. Last updated on Aug 21, 2024.

Note: This document provides detailed information about Adzynma Side Effects associated with apadamtase alfa, recombinant. Some dosage forms listed on this page may not apply specifically to the brand name Adzynma.

Applies to apadamtase alfa, recombinant: intravenous powder for solution.

Serious side effects of Adzynma

Along with its needed effects, apadamtase alfa, recombinant (the active ingredient contained in Adzynma) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking apadamtase alfa, recombinant:

More common side effects

  • body aches or pain
  • chills
  • cough
  • ear congestion
  • fever
  • headache, severe and throbbing
  • loss of voice
  • sneezing
  • sore throat
  • stuffy or runny nose
  • trouble breathing
  • unusual tiredness or weakness

Incidence not known

  • blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • chest tightness
  • confusion
  • difficulty swallowing
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • fast, pounding, or irregular heartbeat or pulse
  • hives, itching, skin rash
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • nausea
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • restlessness
  • unusual drowsiness, dullness, or feeling of sluggishness
  • vomiting

Other side effects of Adzynma

Some side effects of apadamtase alfa, recombinant may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

Managing side effects (general information)

For healthcare professionals

Applies to apadamtase alfa, recombinant: intravenous kit.

General adverse events

The most common adverse reactions reported in 5% or more patients were headache, diarrhea, migraine, abdominal pain, nausea, upper respiratory tract infection, dizziness, and vomiting.[Ref]

Gastrointestinal

Respiratory

Nervous system

References

1. (2023) "Product Information. Adzynma (apadamtase alfa, recombinant)." Takeda Pharmaceuticals America

Further information

Adzynma side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer